Geneva, June 22 -- International Clinical Trials Registry received information related to the study (ChiCTR2600126602) titled 'Screening and Validation of Multi-omics Molecular Biomarkers in Distant Metastatic Papillary Thyroid Carcinoma' on June 12.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: China-Japan Friendship Hospital
Condition:
Papillary thyroid carcinoma
Intervention:
The Distant Metastasis Group:N/A
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-06-12
Target Sample Size: The Distant Metastasis Group:48;Non-distant Metastasis Group:12;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=324851
Published by...